The Board and the Management Team of Opterion Health AG thanks🙏 Stefan Wohlfeil for his support and his outstanding contribution to the continuing success of the company.
Stefan Wohlfeil has decided to retire and step down as a member of the Board of Directors, but remains a partner and shareholder.
At the Opterion Health AG extraordinary General Meeting, held on September 19, 2023, the shareholders elected Jan-Anders Karlsson and Robert Leitz as new members of the Board of Directors.
David Ebsworth, Chairman of Opterion Health, commented: “Stefan has played a critical role in the development of the company, which is now progressing towards the clinic 🩺 with an innovative approach to peritoneal dialysis that could bring major benefits for patients. We are very grateful for Stefan’s continuing commitment to helping shape the company as a partner and investor. I would like to welcome Jan-Anders and Robert as new Board members. Their expertise and experience are an excellent fit for Opterion Health as we take our lead product to the next level.”